Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 39

1.

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Kräusslich HG, Mizokami M, Bartenschlager R, Liang TJ.

Nat Med. 2005 Jul;11(7):791-6. Epub 2005 Jun 12. Erratum in: Nat Med. 2005 Aug;11(8):905.

2.

Complete replication of hepatitis C virus in cell culture.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM.

Science. 2005 Jul 22;309(5734):623-6. Epub 2005 Jun 9.

3.

Robust hepatitis C virus infection in vitro.

Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV.

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9. Epub 2005 Jun 6.

4.

An in vitro model of hepatitis C virion production.

Heller T, Saito S, Auerbach J, Williams T, Moreen TR, Jazwinski A, Cruz B, Jeurkar N, Sapp R, Luo G, Liang TJ.

Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2579-83. Epub 2005 Feb 8.

5.

Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.

Kato T, Date T, Miyamoto M, Zhao Z, Mizokami M, Wakita T.

J Virol. 2005 Jan;79(1):592-6.

6.

Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54. Epub 2004 Jun 25.

7.

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.

Yu MY, Bartosch B, Zhang P, Guo ZP, Renzi PM, Shen LM, Granier C, Feinstone SM, Cosset FL, Purcell RH.

Proc Natl Acad Sci U S A. 2004 May 18;101(20):7705-10. Epub 2004 May 10.

8.

Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells.

Date T, Kato T, Miyamoto M, Zhao Z, Yasui K, Mizokami M, Wakita T.

J Biol Chem. 2004 May 21;279(21):22371-6. Epub 2004 Feb 26.

9.

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.

Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M, Wakita T.

Gastroenterology. 2003 Dec;125(6):1808-17.

PMID:
14724833
11.
12.

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. Epub 2003 May 21.

13.
14.

Processing of hepatitis C virus core protein is regulated by its C-terminal sequence.

Kato T, Miyamoto M, Furusaka A, Date T, Yasui K, Kato J, Matsushima S, Komatsu T, Wakita T.

J Med Virol. 2003 Mar;69(3):357-66.

PMID:
12526046
15.

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Blight KJ, McKeating JA, Rice CM.

J Virol. 2002 Dec;76(24):13001-14.

16.

Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14416-21. Epub 2002 Oct 21.

17.

Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.

McLauchlan J, Lemberg MK, Hope G, Martoglio B.

EMBO J. 2002 Aug 1;21(15):3980-8.

18.

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R.

J Virol. 2002 Apr;76(8):4008-21.

20.

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.

J Clin Invest. 2002 Jan;109(2):221-32.

Supplemental Content

Support Center